Search
Medicaid Monitor
Saturday, November 21, 2026 · Updated Fri 12:06 PM MT · 52 stories on Friday, November 20
Medicaid Monitor Pro
Sat, Nov 21 · 52 stories on Friday, November 20PRO
Archive

All stories

Continuing from the front page · Show all

3,629 more stories · Page 150 of 182

Wednesday, July 22 · 13 stories

  1. Legal · TX

    AstraZeneca Pays Texas $34M to Settle Medicaid Kickback Claims

    AstraZeneca Pharmaceuticals LP agreed to pay $33,998,000 to Texas to resolve allegations that it provided illegal remuneration to healthcare providers in connection with prescriptions for drugs covered by the state's Medicaid program. The settlement addresses potential violations of anti-kickback statutes related to inducements tied to Medicaid prescribing. Texas Medicaid managed care organizations that reimbursed claims for the implicated drugs during the alleged period may have paid inflated costs tied to these arrangements. The settlement follows state enforcement action under Texas Medicaid fraud statutes.

    jdsupra.com · 122 days ago
  2. Federal Policy

    CMS Proposes Tighter Remote Patient Monitoring Requirements in 2027 Physician Fee Schedule

    CMS published a proposed rule on July 16, 2026, that would tighten requirements for remote patient monitoring (RPM) services in the Calendar Year 2027 Medicare Physician Fee Schedule. The changes respond to Office of Inspector General reports flagging program integrity concerns about RPM billing. The proposed rule affects how providers document and bill for remote monitoring services under Medicare. Comments on the proposed rule are typically due 60 days after publication in the Federal Register.

    jdsupra.com · 122 days ago
  3. Federal Policy

    Webinar Examines H.R.1 Impact on Medicaid Maternal and Infant Health Programs

    A webinar titled 'Medicaid Connections: Maternal and Infant Health and Justice' addresses how H.R.1 legislation affects Medicaid-funded maternity care. The session focuses on reproductive justice and optimizing Medicaid to fund holistic, culturally centered care including midwifery and doula services. As the nation's largest payer for maternity care, Medicaid plays a central role in addressing systemic health inequities for maternal and infant populations. The webinar provides guidance for policymakers on funding structures that support comprehensive perinatal services.

    Georgetown CCF · 122 days ago
  4. Legal

    D.C. Circuit Rules Drugmakers Need HHS Approval for 340B Rebate Models

    The U.S. Court of Appeals for the D.C. Circuit ruled July 21, 2026, that pharmaceutical manufacturers cannot implement 340B rebate models without prior approval from the HHS secretary. The decision upheld lower court rulings against Novartis, Johnson & Johnson Health Care Systems, Bristol Myers Squibb, and Eli Lilly. The ruling reinforces federal authority over 340B program administration and blocks manufacturer attempts to unilaterally restructure drug discount delivery mechanisms. For Medicaid managed care organizations with provider networks that include 340B-eligible entities, the decision preserves existing 340B purchasing pathways and prevents disruption to contract pharmacy arrangements that affect covered entity participation and pharmacy network stability.

    Becker's · 122 days ago
  5. Federal Policy

    CMS Proposes Ban on Medicare Payment for Third-Party Remote Patient Monitoring

    CMS has issued a proposed rule that would prohibit Medicare payment for remote patient monitoring services delivered by third-party vendors. Health systems, physician groups, and telehealth trade associations are opposing the proposal, citing concerns about disrupted RPM programs and unclear reimbursement alternatives. The proposal has prompted some organizations to pause RPM expansion plans and appears to conflict with congressional support for broader telehealth access. If finalized, the policy would require Medicare providers to deliver RPM services directly rather than through vendor arrangements.

    Becker's · 122 days ago
  6. Federal Policy

    Rural Hospital CEO Criticizes $50B Federal Rural Health Transformation Program Structure

    A rural hospital CEO has publicly criticized the $50 billion Rural Health Transformation Program, which launched last year following Medicaid cuts under HR-1. Rural health executives are questioning the program's design, citing concerns that states control funding distribution, eligible uses are narrowly defined, and the structure may not adequately address care access challenges in communities affected by Medicaid reductions. The criticism reflects broader implementation concerns among rural providers about whether federal support will effectively reach facilities serving Medicaid populations.

    Becker's · 122 days ago
  7. State Policy · CO

    Colorado Medicaid Owes $8 Million in Federal Funds for HCBS Claims

    An Office of Inspector General audit found Colorado Medicaid improperly claimed at least $8 million in federal funds for in-home disability care services. The OIG identified an additional $45 million in federal payments requiring further review. State officials acknowledged billing errors but stated no fraud occurred. The audit examined home and community-based services claims, a program area where improper billing has drawn increased federal scrutiny. Colorado must repay the federal share of identified improper payments.

    Colorado Sun · 122 days ago
  8. Federal Policy

    AHA Urges CMS to Scale Back Medicaid State-Directed Payment Limits in Proposed Rule

    The American Hospital Association submitted comments July 21, 2026, opposing portions of a CMS proposed rule implementing reconciliation-mandated changes to Medicaid state-directed payments. The rule proposes new limits on targeted fee-for-service payments and SDP design that exceed statutory requirements. CMS projects the rule would reduce Medicaid payments by $510.1 billion over 10 years—more than triple the Congressional Budget Office estimate of $149.4 billion. AHA argues the cuts would reduce care access, worsen workforce shortages, and threaten hospital financial viability, urging CMS to rescind provisions beyond what Congress required and mitigate SDP reductions.

    aha.org · 122 days ago
  9. Federal Policy

    CMS Proposes New Provider Tax Thresholds, Phases Out 6% Hold Harmless Rule

    CMS released a proposed rule updating Medicaid provider tax policies following the July 2025 reconciliation law. The rule replaces the current 6% indirect hold harmless threshold with state- and provider class-specific thresholds based on taxes enacted as of July 4, 2025, and implements phased reductions for Medicaid expansion states starting in fiscal year 2028. CMS proposes to sunset the current 75/75 compliance test and establishes a new "Services of Health Insurers" provider tax class, bringing existing state taxes on health insurers under federal oversight. Comments are due 60 days after Federal Register publication.

    aha.org · 122 days ago
  10. Legal

    23 States Sue CMS Over Medicaid Work Requirements Rule Exemptions

    On June 29, 2026, twenty-three states, two governors, and the District of Columbia filed suit in U.S. District Court for Massachusetts challenging CMS implementation of Medicaid work requirements under the One Big Beautiful Bill Act. Plaintiffs allege CMS unlawfully narrowed exemptions for medically frail beneficiaries. The litigation seeks to block enforcement of the work requirements rule pending judicial review. This lawsuit directly affects managed care organizations responsible for identifying medically frail populations, verifying exemptions, and ensuring compliance with work requirement reporting.

    jdsupra.com · 122 days ago

Tuesday, July 21 · 15 stories

  1. Industry

    Novo Nordisk Sues Eli Lilly Over Obesity Drug Advertising Claims

    Novo Nordisk has filed a lawsuit against Eli Lilly alleging misleading advertising of Lilly's GLP-1 obesity medications. The suit, which follows a cease-and-desist demand, claims Lilly is using deceptive advertisements to portray its products as broadly superior to Novo's competing medicines. Lilly has responded that its marketing campaign is truthful. The legal action comes as both manufacturers compete intensively in the rapidly growing obesity treatment market.

    Healthcare Dive · 123 days ago
  2. Federal Policy

    Senate Democrat Proposes Medicare Enrollment for All Children Under Age 26

    Sen. Andy Kim (D-N.J.) introduced legislation to automatically enroll all American children in Medicare from birth through age 25, calling the proposal MediKids. The bill would create universal federal coverage for children regardless of family income. No timeline for committee consideration or floor action has been announced. The proposal would fundamentally restructure pediatric coverage currently delivered through Medicaid, CHIP, and commercial insurance, though passage prospects remain uncertain given divided government.

    The Hill · 123 days ago
  3. Federal Policy

    Four House Republicans Join Democratic ACA Discharge Petition

    Four Republican members of the U.S. House of Representatives joined a Democratic discharge petition related to the Affordable Care Act on December 17, 2025. The Association for Community Affiliated Plans issued a statement from CEO Margaret A. Murray responding to this development. A discharge petition can force a floor vote on legislation if it receives 218 signatures. The bipartisan support suggests potential movement on ACA-related legislation that could affect Medicaid expansion states and marketplace programs.

    communityplans.net · 123 days ago
  4. State Policy · NM

    New Mexico Lawmakers Criticize Slow Rollout of Behavioral Health System Reforms

    Bipartisan New Mexico legislators voiced frustration over delays in implementing the state's behavioral health system overhaul during a Monday legislative session. The criticism focuses on the pace of program deployment intended to rebuild behavioral health infrastructure and service delivery. The concerns come amid ongoing challenges in the state's behavioral health network, which affects Medicaid managed care organizations responsible for coordinating behavioral health services for enrollees. The delays may impact MCO network adequacy requirements and care coordination for members with behavioral health needs.

    sourcenm.com · 123 days ago
  5. Federal Policy · CA

    HHS Defers $1 Billion in Federal Medicaid Payments to Two States

    HHS and CMS announced Tuesday they deferred over $1 billion in federal Medicaid payments to two states, including $867.5 million to California, citing high-risk claims including home-based services. The deferrals represent a federal payment hold while CMS reviews claims for potential fraud, waste, or abuse. The action takes effect immediately. This is significant because payment deferrals can strain state budgets and delay provider payments, potentially disrupting network adequacy and access to home and community-based services that many MCOs coordinate or manage under managed long-term services and supports contracts.

    Home Health Care News · 123 days ago
  6. State Policy · DE

    Delaware Enacts Hospital Price Caps, Charity Care Expansion, PE Acquisition Moratorium

    Delaware Governor Matt Meyer signed three healthcare bills on July 20, 2026, that will phase in hospital price caps, expand charity care eligibility, and temporarily block private equity acquisitions of nonprofit hospitals. The legislation aims to improve healthcare affordability and access in Delaware. The price cap implementation will be delayed to allow a phased approach. These changes affect hospital reimbursement structures and access requirements that impact Medicaid managed care organizations contracting with Delaware hospitals.

    Becker's · 123 days ago
  7. Industry

    Stanford Expert Discusses Evolving AI Regulation in Health Care Delivery

    Dr. Michelle Mello of Stanford's Healthcare Ethical Assessment Lab for AI discussed regulatory frameworks for artificial intelligence deployment in clinical settings during an interview. The conversation addressed accountability structures, oversight mechanisms, and liability questions as AI tools increasingly enter medical practice. While the discussion covers broader health care AI governance, specific Medicaid managed care implications were not detailed. The podcast explores ongoing policy development rather than reporting finalized regulatory action.

    KFF Research · 123 days ago
  8. Managed Care

    Health Insurers Report Progress on Prior Authorization Simplification One Year After Voluntary Pledge

    In June 2025, major health insurers committed to simplifying and reducing prior authorization requirements for plans covering 257 million Americans. One year later, payers report progress on their voluntary commitments, though implementation remains incomplete. The initiative affects commercial, Medicare Advantage, and potentially Medicaid managed care plans. For Medicaid MCOs, this signals industry-wide movement toward streamlined utilization management practices that may inform state contract requirements and CMS managed care rules.

    Becker's · 123 days ago
  9. Federal Policy

    Maryland Court Enjoins Eight Provisions of CMS 2027 Marketplace Payment Rule

    A federal district court in Maryland issued a preliminary injunction on July 16, 2026, blocking eight provisions of CMS's 2027 notice of benefit and payment parameters final rule. The enjoined provisions include expanded out-of-pocket maximums for bronze and catastrophic plans, broader catastrophic plan eligibility, relaxed network adequacy standards, and a new pathway for non-network plans to qualify as marketplace coverage. The court found plaintiffs likely to succeed on Administrative Procedure Act claims and that irreparable harm would occur without relief. The injunction took effect July 20, 2026, while the remainder of the rule proceeded as scheduled.

    aha.org · 123 days ago
  10. Federal Policy

    Compounding Pharmacies Modify GLP-1 Formulations to Circumvent FDA Compounding Restrictions

    A JAMA Health Forum study published July 17, 2026 finds that some compounding pharmacies are making minor compositional changes to semaglutide and tirzepatide products to evade FDA restrictions on compounding copies of approved drugs. The FDA previously added these GLP-1 medications to its drug shortage list due to surging demand, which legally permitted compounding. As shortages resolve and FDA moves to restrict compounding of these products, some pharmacies are altering formulations to maintain legal compounding status. This affects Medicaid managed care organizations that cover GLP-1s for diabetes and obesity, as it creates uncertainty around formulary management, prior authorization protocols, and pharmacy network oversight.

    Becker's · 123 days ago

Get the daily briefing.